Edward J. Gutmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Edward J. Gutmann has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Darcy A. Kerr
Dartmouth-Hitchcock Medical Center
4 shared publications - Jonathan D. Marotti
Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
4 shared publications Arief A. Suriawinata
Emerging Diagnostic and Investigative Technologies Department of Pathology and Laboratory Medicine Dartmouth Hitchcock Medical Center Lebanon New Hampshire USA
2 shared publicationsBrock C. Christensen
Department of Epidemiology Dartmouth College Geisel School of Medicine Hanover New Hampshire USA
2 shared publicationsCaroline P. Dodge
Cambridge Health Alliance Cambridge Massachusetts USA
2 shared publicationsJonathan D. Marotti
Department of Pathology and Laboratory Medicine Dartmouth‐Hitchcock Medical Center Lebanon New Hampshire USA
2 shared publications
Latest Publications
- Open Access
- 27 February 2024
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 148 (6) , 631-632
The Pathologist Pipeline: A Brief Look at the “Other End”
- 27 February 2024
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 148 (6) , 631-632
Open AccessThe Pathologist Pipeline: A Brief Look at the “Other End”
- 21 December 2023
- Published by Wiley in Cytopathology
- Vol. 35 (3) , 425-426
Guar beans in a peritoneal fluid sample
- 21 December 2023
- Published by Wiley in Cytopathology
- Vol. 35 (3) , 425-426
Guar beans in a peritoneal fluid sample
- 12 September 2023
- Published by Wiley in Cytopathology
- Vol. 35 (1) , 157-159
Metastatic gastrointestinal stromal tumour in pleural fluid 19 years after initial diagnosis
- 12 September 2023
- Published by Wiley in Cytopathology
- Vol. 35 (1) , 157-159
Metastatic gastrointestinal stromal tumour in pleural fluid 19 years after initial diagnosis
- 28 June 2023
- Published by Wiley in Cancer Cytopathology
- Vol. 131 (10) , 637-654
Large‐scale validation study of an improved semiautonomous urine cytology assessment tool: AutoParis‐X
Background: Adopting a computational approach for the assessment of urine cytology specimens has the potential to improve the efficiency, accuracy, and reliability of bladder cancer screening, which has heretofore relied on semisubjective manual assessment methods. As rigorous, quantitative criteria and guidelines have been introduced for improving screening practices (e.g., The Paris System for Reporting Urinary Cytology), algorithms to emulate semiautonomous diagnostic decision‐making have lagged behind, in part because of the complex and nuanced nature of urine cytology reporting.Methods: In this study, the authors report on the development and large‐scale validation of a deep‐learning tool, AutoParis‐X, which can facilitate rapid, semiautonomous examination of urine cytology specimens.Results: The results of this large‐scale, retrospective validation study indicate that AutoParis‐X can accurately determine urothelial cell atypia and aggregate a wide variety of cell‐related and cluster‐related information across a slide to yield an atypia burden score, which correlates closely with overall specimen atypia and is predictive of Paris system diagnostic categories. Importantly, this approach accounts for challenges associated with the assessment of overlapping cell cluster borders, which improve the ability to predict specimen atypia and accurately estimate the nuclear‐to‐cytoplasm ratio for cells in these clusters.Conclusions: The authors developed a publicly available, open‐source, interactive web application that features a simple, easy‐to‐use display for examining urine cytology whole‐slide images and determining the level of atypia in specific cells, flagging the most abnormal cells for pathologist review. The accuracy of AutoParis‐X (and other semiautomated digital pathology systems) indicates that these technologies are approaching clinical readiness and necessitates full evaluation of these algorithms in head‐to‐head clinical trials.
- 28 June 2023
- Published by Wiley in Cancer Cytopathology
- Vol. 131 (10) , 637-654
Large‐scale validation study of an improved semiautonomous urine cytology assessment tool: AutoParis‐X
Background: Adopting a computational approach for the assessment of urine cytology specimens has the potential to improve the efficiency, accuracy, and reliability of bladder cancer screening, which has heretofore relied on semisubjective manual assessment methods. As rigorous, quantitative criteria and guidelines have been introduced for improving screening practices (e.g., The Paris System for Reporting Urinary Cytology), algorithms to emulate semiautonomous diagnostic decision‐making have lagged behind, in part because of the complex and nuanced nature of urine cytology reporting.Methods: In this study, the authors report on the development and large‐scale validation of a deep‐learning tool, AutoParis‐X, which can facilitate rapid, semiautonomous examination of urine cytology specimens.Results: The results of this large‐scale, retrospective validation study indicate that AutoParis‐X can accurately determine urothelial cell atypia and aggregate a wide variety of cell‐related and cluster‐related information across a slide to yield an atypia burden score, which correlates closely with overall specimen atypia and is predictive of Paris system diagnostic categories. Importantly, this approach accounts for challenges associated with the assessment of overlapping cell cluster borders, which improve the ability to predict specimen atypia and accurately estimate the nuclear‐to‐cytoplasm ratio for cells in these clusters.Conclusions: The authors developed a publicly available, open‐source, interactive web application that features a simple, easy‐to‐use display for examining urine cytology whole‐slide images and determining the level of atypia in specific cells, flagging the most abnormal cells for pathologist review. The accuracy of AutoParis‐X (and other semiautomated digital pathology systems) indicates that these technologies are approaching clinical readiness and necessitates full evaluation of these algorithms in head‐to‐head clinical trials.
- 26 June 2023
- Published by Wiley in Cancer Cytopathology
- Vol. 131 (9) , 561-573
Examining longitudinal markers of bladder cancer recurrence through a semiautonomous machine learning system for quantifying specimen atypia from urine cytology
Background: Urine cytology is generally considered the primary approach for screening for recurrence of bladder cancer. However, it is currently unclear how best to use cytological examinations for assessment and early detection of recurrence, beyond identifying a positive finding that requires more invasive methods to confirm recurrence and decide on therapeutic options. Because screening programs are frequent, and can be burdensome, finding quantitative means to reduce this burden for patients, cytopathologists, and urologists is an important endeavor and can improve both the efficiency and reliability of findings. Additionally, identifying ways to risk‐stratify patients is crucial for improving quality of life while reducing the risk of future recurrence or progression of the cancer.Methods: In this study, a computational machine learning tool, AutoParis‐X, was leveraged to extract imaging features from urine cytology examinations longitudinally to study the predictive potential of urine cytology for assessing recurrence risk. This study examined how the significance of imaging predictors changes over time before and after surgery to determine which predictors and time periods are most relevant for assessing recurrence risk.Results: Results indicate that imaging predictors extracted using AutoParis‐X can predict recurrence as well or better than traditional cytological/histological assessments alone and that the predictiveness of these features is variable across time, with key differences in overall specimen atypia identified immediately before tumor recurrence.Conclusions: Further research will clarify how computational methods can be effectively used in high‐volume screening programs to improve recurrence detection and complement traditional modes of assessment.
- 26 June 2023
- Published by Wiley in Cancer Cytopathology
- Vol. 131 (9) , 561-573
Examining longitudinal markers of bladder cancer recurrence through a semiautonomous machine learning system for quantifying specimen atypia from urine cytology
Background: Urine cytology is generally considered the primary approach for screening for recurrence of bladder cancer. However, it is currently unclear how best to use cytological examinations for assessment and early detection of recurrence, beyond identifying a positive finding that requires more invasive methods to confirm recurrence and decide on therapeutic options. Because screening programs are frequent, and can be burdensome, finding quantitative means to reduce this burden for patients, cytopathologists, and urologists is an important endeavor and can improve both the efficiency and reliability of findings. Additionally, identifying ways to risk‐stratify patients is crucial for improving quality of life while reducing the risk of future recurrence or progression of the cancer.Methods: In this study, a computational machine learning tool, AutoParis‐X, was leveraged to extract imaging features from urine cytology examinations longitudinally to study the predictive potential of urine cytology for assessing recurrence risk. This study examined how the significance of imaging predictors changes over time before and after surgery to determine which predictors and time periods are most relevant for assessing recurrence risk.Results: Results indicate that imaging predictors extracted using AutoParis‐X can predict recurrence as well or better than traditional cytological/histological assessments alone and that the predictiveness of these features is variable across time, with key differences in overall specimen atypia identified immediately before tumor recurrence.Conclusions: Further research will clarify how computational methods can be effectively used in high‐volume screening programs to improve recurrence detection and complement traditional modes of assessment.
- 27 December 2022
- Published by Wiley in Cancer Cytopathology
- Vol. 131 (6) , 344-346
Preclinical medical students and pathologists: Departing from the text
- 27 December 2022
- Published by Wiley in Cancer Cytopathology
- Vol. 131 (6) , 344-346
Preclinical medical students and pathologists: Departing from the text
- 28 February 2022
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 46 (8) , e94-e96
Pathologist-Patient Visits—Revisited
Direct pathologist-patient encounters are infrequent, but there has been a modest movement toward such interactions in the past 2 decades. The present article places that movement in perspective. It includes a discussion of diverse factors—including congressional laws, the views of department chairs, and progress in artificial intelligence—that could promote pathologist-patient interactions and also reviews factors that might deter such encounters.
- 28 February 2022
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 46 (8) , e94-e96
Pathologist-Patient Visits—Revisited
Direct pathologist-patient encounters are infrequent, but there has been a modest movement toward such interactions in the past 2 decades. The present article places that movement in perspective. It includes a discussion of diverse factors—including congressional laws, the views of department chairs, and progress in artificial intelligence—that could promote pathologist-patient interactions and also reviews factors that might deter such encounters.
- Open Access
- 18 June 2021
- Published by Wiley in Cancer Cytopathology
- Vol. 129 (12) , 923-925
Pathology Grand Rounds in a Postpandemic World
- 18 June 2021
- Published by Wiley in Cancer Cytopathology
- Vol. 129 (12) , 923-925
Open AccessPathology Grand Rounds in a Postpandemic World
- Open Access
- 10 February 2021
- Published by Wiley in Cancer Cytopathology
- Vol. 129 (7) , 566-567
Building on recent cytomorphologic descriptions of NTRK‐rearranged thyroid carcinoma
- 10 February 2021
- Published by Wiley in Cancer Cytopathology
- Vol. 129 (7) , 566-567
Open AccessBuilding on recent cytomorphologic descriptions of NTRK‐rearranged thyroid carcinoma
- 30 October 2020
- Published by Wiley in Cancer Cytopathology
- Vol. 128 (12) , 883-884
The doctors' lot
Establishing and maintaining collegial relationships among physicians and other health professionals is challenging. However, these relationships are important for the well‐being of the health care workers and for patient care. This commentary addresses the importance of our direct, in‐person interactions and highlights a special place where they may occur.
- 30 October 2020
- Published by Wiley in Cancer Cytopathology
- Vol. 128 (12) , 883-884
The doctors' lot
Establishing and maintaining collegial relationships among physicians and other health professionals is challenging. However, these relationships are important for the well‐being of the health care workers and for patient care. This commentary addresses the importance of our direct, in‐person interactions and highlights a special place where they may occur.